Psychiatr. praxi. 2012;13(1):35-37

Depression in cancer patients

MUDr.Radkin Honzák, CSc.
Ústav všeobecného lékařství 1. LF UK, Praha

Depressive disorders have frequently been encountered in cancer patients with prevalence > 20%. During routine oncology daily care,

depression screening, assessment and treatment are of paramount importance for the outcome, compliance, and quality of life in patients.

The article draws attention to some useful diagnostic tools and newer knowledge in therapy.

Keywords: oncology, depression, suicide, diagnosis, antidepressants, CYP 450, psychotherapy

Published: January 3, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Honzák R. Depression in cancer patients. Psychiatr. praxi. 2012;13(1):35-37.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Chochinov HM. Dignity and the essence of medicine: the A, B, C, and D of dignity conserving care. BMJ 2007, 28; 335(7612): 184-187. Go to original source... Go to PubMed...
    2. Ballenger JC, Davidson JRT, Lecrubier Y, et al. Consensus statement on depression, anxiety, and oncology. J Clin Psychiat 2001; 62(Suppl 8): 64-67.
    3. Průša I. Deprese a úzkost v ambulanci praktického lékaře. Med pro Praxi 2006; 3: 136-139.
    4. McDaniel JS, Musselman DL, Porter NR, et al. Deprese u onkologických pacientů. Diagnóza, biologie, léčba. JAMA-CS 1995; 3(5): 441-449.
    5. Myint AM, Schwarz MJ, Steinbusch HW, Leonard BE. Neuropsychiatric disorders related to interferon and interleukins treatment. Metab Brain Dis. 2009; 24(1): 55-68. Go to original source... Go to PubMed...
    6. Debien C, De Chouly De Lenclave MB, et al. Alpha-interferon and mental disorders. Encephale 2001; 27(4): 308-317. Go to PubMed...
    7. Jones RD. Depression and anxiety in oncology: the oncologist's perspective. J Clin Psychiatry 2001; 62(Suppl 8): 52-55.
    8. Mitchell AJ, Baker-Glenn EA, Granger L, Symonds P. Can the Distress Thermometer be improved by additional mood domains? Part I. Initial validation of the Emotion Thermometers tool. Psycho-Oncology (2009) Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/ pon.1523.
    9. Bell RA, Franks P, Duberstein PR, et al. Suffering in Silence: Reasons for Not Disclosing Depression in Primary Care. Ann Fam Med 2011; 9(5): 439-446. Go to original source... Go to PubMed...
    10. Johnson TV, Garlow SJ, Brawley OW, Master VA. Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology. Psychooncology 2011, doi: 10.1002/pon.1905. Go to original source... Go to PubMed...
    11. Bultz BD, Groff SL, Fitch M, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psycho-Oncology 2011; 20: 463-469. doi: 10.1002/pon.1932. Go to original source... Go to PubMed...
    12. Hurria A, Li D, Hansen K, et al. Distress in Older Patients With Cancer. JCO, 2009;27 (26): 4346-4351 doi: 10.1200/JCO.2008.19.9463. Go to original source... Go to PubMed...
    13. Smith GF, Toonen TR. Primary care of the patient with cancer. Am Fam Physician 2007; 75(8): 1207-1214. Go to PubMed...
    14. Portela MA, Rubiales AS, Centeno C. The use of psychostimulants in cancer patients. Curr Opin Support Palliat Care. 2011; 5(2): 164-168. Go to original source... Go to PubMed...
    15. Bendová M, Honzák R. V nouzi poznáš přítele. In: Karešová J, a kol. Praktické rady pro onkologické pacienty. Maxdorf, Praha 2010: 113-115.
    16. Lussier D, Huskey AG, Portenoy RK. Adjuvant analgesics in cancer pain management. Oncologist 2004; 9(5): 571-591; Full text FREE. Go to original source... Go to PubMed...
    17. Mitra R, Jones S. Adjuvant Analgesics in Cancer Pain: A Review. Am J Hosp Palliat Care. 2011 Jun 28. [Epub ahead of print]. Go to original source... Go to PubMed...
    18. Desmarais JE, Looper KJ. Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. J Clin Psychiatry 2009; 70(12): 1688-1697. Go to original source... Go to PubMed...
    19. Barton MK. Drug interactions in cancer patients receiving antidepressants are common, researchers report. CA Cancer J Clin. 2011 Aug 8. doi: 10.3322/caac.20127. Go to original source... Go to PubMed...
    20. Kasper S, McEwen BS. Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs 2008; 22(1): 15-26. Go to original source... Go to PubMed...
    21. Turner J, Kelly B, Clarke D, et al. A randomised trial of a psychosocial intervention for cancer patients integrated into routine care: the PROMPT study (promoting optimal outcomes in mood through tailored psychosocial therapies). BMC Cancer 2011; 11: 48. Published online 2011 February 1. doi: 10.1186/1471-2407-11-48Dostupné z: http://www.biomedcentral.com/1471-2407/11/48. Go to original source... Go to PubMed...
    22. Travado L, Grassi L, Gil F, et al. Do spirituality and faith make a difference? Report from the Southern European Psycho-Oncology Study Group. Palliat Support Care 2010; 8(4): 405-413. Go to original source... Go to PubMed...
    23. Geue K, Goetze H, Buttstaedt M, et al. An overview of art therapy interventions for cancer patients and the results of research. Complement Ther Med. 2010; 18(3-4): 160-170. Go to original source... Go to PubMed...
    24. Walker LM, Bischoff TF, Robinson JW. Supportive expressive group therapy for women with advanced ovarian cancer. Int J Group Psychother 2010; 60(3): 407-427. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.